High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on...

Area of Science:

• Nephrology
• Cardiology
• Bone Metabolism

Background:

• Coronary artery calcifications (CACs) are prevalent in chronic kidney disease (CKD) patients on dialysis (CKD-5D).
• CAC progression is linked to cardiovascular events, the primary cause of mortality in this population.
• A connection between bone and vascular calcification is established.

Purpose of the Study:

• To identify noninvasive predictors of CAC progression in adult CKD-5D patients.
• To evaluate the role of bone mineral density (BMD) and novel bone markers in predicting CAC progression.

Main Methods:

• Prospective study involving 213 adult CKD-5D patients at baseline and 122 completing 1-year follow-up.
• Measurements included routine blood tests, CAC scoring, BMD (quantitative computed tomography), and serum bone markers.
• Statistical analysis identified independent predictors of baseline CAC and CAC progression.

Main Results:

• At baseline, 80% had measurable CAC, and 50% had high-risk scores (>400).
• Baseline CAC predictors included coronary artery disease, diabetes, dialysis vintage, FGF-23, and age; spinal BMD was an inverse predictor.
• Over 1 year, 75% of completers showed CAC increases. Independent risk factors for progression were age, elevated parathyroid hormone, and osteoporosis.

Conclusions:

• Bone health plays a significant role in the prevalence and progression of CAC in CKD-5D patients.
• Noninvasive bone markers and BMD measurements can aid in predicting cardiovascular risk in this population.
• Targeting bone metabolism may offer therapeutic strategies to reduce cardiovascular events in CKD-5D.